The COVID-19 Live Vaccine Tracker
Here is a compilation of the COVID-19 vaccine candidates that are in phases 1-3.
Here is a compilation of the COVID-19 vaccine candidates that are in phases 1-3.
A study presented at ESCMID examines the efficacy and safety of the vaccine in older populations.
Check out the latest studies, management strategies, patient advocacy, and other important news involving this condition.
A study presented at ESCMID aims to understand ribotype 955 as a new challenge in C difficile management.
This cephalosporin antibiotic was examined against colistin-susceptible gram-negative infections.
A large study at ESCMID shows the therapy was associated with a significantly lower mortality at 14-days and 28-days.
A novel approach using this emerging technology looks to interfere with antibiotic resistance expression and reduce this global health issue.
A study finds that despite the development of some new agents for highly-resistant pathogens, prescribers are reluctant to utilize these therapies.
Insights into host-directed therapies (HDT) for tuberculosis (TB) gaining traction among experts aiming to combat the disease’s various forms, including drug-resistant strains.
A study finds that despite the development of some new agents for highly-resistant pathogens, prescribers are reluctant to utilize these therapies.
Insights from Pranay Sinna MD on a multicenter prospective cohort study on household contacts.